Your browser doesn't support javascript.
loading
SARS-CoV-2 Seroprevalence among Healthcare Workers in General Hospitals and Clinics in Japan.
Yoshihara, Tatsuya; Ito, Kazuya; Zaitsu, Masayoshi; Chung, Eunhee; Aoyagi, Izumi; Kaji, Yoshikazu; Tsuru, Tomomi; Yonemura, Takuma; Yamaguchi, Koji; Nakayama, Shinichi; Tanaka, Yosuke; Yurino, Nobuo; Koyanagi, Hideki; Matsuki, Shunji; Urae, Ryuji; Irie, Shin.
Afiliação
  • Yoshihara T; Clinical Research Center, SOUSEIKAI Fukuoka Mirai Hospital, Kashiiteriha 3-5-1, Higashi-ku, Fukuoka 813-0017, Japan.
  • Ito K; SOUSEIKAI Clinical Epidemiological Research Center, Kashiiteriha 3-5-1, Higashi-ku, Fukuoka 813-0017, Japan.
  • Zaitsu M; College of Healthcare Management, Takayanagi 960-4, Setaka-machi, Miyama 835-0018, Japan.
  • Chung E; Department of Public Health, Dokkyo Medical University School of Medicine, 880 Kitakobayashi, Mibu-machi, Shimotsuga-gun, Tochigi 321-0293, Japan.
  • Aoyagi I; SOUSEIKAI Global Clinical Research Center, Kashiiteriha 3-5-1, Higashi-ku, Fukuoka 813-0017, Japan.
  • Kaji Y; Department of Internal Medicine, SOUSEIKAI Fukuoka Mirai Hospital, Kashiiteriha 3-5-1, Higashi-ku, Fukuoka 813-0017, Japan.
  • Tsuru T; SOUSEIKAI Hakata Clinic, 6-18 Tenyamachi, Hakata-ku, Fukuoka 812-0025, Japan.
  • Yonemura T; SOUSEIKAI PS Clinic, 6-18 Tenyamachi, Hakata-ku, Fukuoka 812-0025, Japan.
  • Yamaguchi K; SOUSEIKAI Sumida Hospital, 1-29-1, Honjo, Sumida-ku, Tokyo 130-0004, Japan.
  • Nakayama S; SOUSEIKAI Nishikumamoto Hospital, 1012 Koga, Tomiaimachi, Minami-ku, Kumamoto 861-4157, Japan.
  • Tanaka Y; SOUSEIKAI Miyata Hospital, 1636 Honjo, Miyawaka, Fukuoka 823-0003, Japan.
  • Yurino N; SOUSEIKAI Kanenokuma Hospital, 3-24-16 Kanenokuma, Hakata-ku, Fukuoka 812-0863, Japan.
  • Koyanagi H; SOUSEIKAI Shinyoshizuka Hospital, 7-6-29, Yoshizuka, Hakata-ku, Fukuoka 812-0041, Japan.
  • Matsuki S; SOUSEIKAI Dodo Clinic, 1-31-13, Nakaikegami, Ota-ku, Tokyo 146-0081, Japan.
  • Urae R; Clinical Research Center, SOUSEIKAI Fukuoka Mirai Hospital, Kashiiteriha 3-5-1, Higashi-ku, Fukuoka 813-0017, Japan.
  • Irie S; SOUSEIKAI, 3-5-1 Kashiiteriha, Higashi-ku, Fukuoka 813-0017, Japan.
Int J Environ Res Public Health ; 18(7)2021 04 05.
Article em En | MEDLINE | ID: mdl-33916399
ABSTRACT
Coronavirus disease 2019 (COVID-19) has become a serious public health problem worldwide. In general, healthcare workers are considered to be at higher risk of COVID-19 infection. However, the prevalence of COVID-19 among healthcare workers in Japan is not well characterized. In this study, we aimed to examine the seroprevalence of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) antibodies among 2160 healthcare workers in hospitals and clinics that are not designated to treat COVID-19 patients in Japan. The prevalence of SARS-CoV-2 immunoglobulin G was 1.2% in August and October 2020 (during and after the second wave of the pandemic in Japan), which is relatively higher than that in the general population in Japan (0.03-0.91%). Because of the higher risk of COVID-19 infection, healthcare workers should be the top priority for further social support and vaccination against SARS-CoV-2.
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: SARS-CoV-2 / COVID-19 Tipo de estudo: Risk_factors_studies Limite: Humans País como assunto: Asia Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: SARS-CoV-2 / COVID-19 Tipo de estudo: Risk_factors_studies Limite: Humans País como assunto: Asia Idioma: En Ano de publicação: 2021 Tipo de documento: Article